XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Dec. 31, 2020   58,201      
Balance at beginning of period at Dec. 31, 2020 $ 421,232 $ 58 $ 702,768 $ (281,594) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Sale of common stock in a public offering, net of offering costs (in shares)   8,547      
Sale of common stock in a public offering, net of offering costs 593,821 $ 9 593,812    
Issuance of common stock for acquisition (in shares)   3,347      
Issuance of common stock for acquisition 147,089 $ 3 147,086    
Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares)   856      
Issuance of common stock on exercise of stock options and vesting of restricted stock units 8,280 $ 1 8,279    
Issuance of common stock under ESPP (in shares)   81      
Issuance of common stock under ESPP 2,353   2,353    
Tax portion of vested restricted stock units (8,307)   (8,307)    
Stock-based compensation expense (employee) 14,687   14,687    
Stock-based compensation expense (non-employee) 45   45    
Stock-based compensation expense (ESPP) 1,055   1,055    
Net loss (65,035)     (65,035)  
Other comprehensive loss (8,140)       (8,140)
Balance at end of period (in shares) at Sep. 30, 2021   71,032      
Balance at end of period at Sep. 30, 2021 1,107,080 $ 71 1,461,778 (346,629) (8,140)
Balance at beginning of period (in shares) at Jun. 30, 2021   67,472      
Balance at beginning of period at Jun. 30, 2021 971,177 $ 67 1,303,610 (332,500) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for acquisition (in shares)   3,347      
Issuance of common stock for acquisition 147,089 $ 3 147,086    
Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares)   181      
Issuance of common stock on exercise of stock options and vesting of restricted stock units 2,844 $ 1 2,843    
Issuance of common stock under ESPP (in shares)   32      
Issuance of common stock under ESPP 1,195   1,195    
Tax portion of vested restricted stock units (824)   (824)    
Stock-based compensation expense (employee) 7,359   7,359    
Stock-based compensation expense (non-employee) 15   15    
Stock-based compensation expense (ESPP) 494   494    
Net loss (14,129)     (14,129)  
Other comprehensive loss (8,140)       (8,140)
Balance at end of period (in shares) at Sep. 30, 2021   71,032      
Balance at end of period at Sep. 30, 2021 1,107,080 $ 71 1,461,778 (346,629) (8,140)
Balance at beginning of period (in shares) at Dec. 31, 2021   71,123      
Balance at beginning of period at Dec. 31, 2021 1,096,514 $ 71 1,468,683 (357,157) (15,083)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares)   464      
Issuance of common stock on exercise of stock options and vesting of restricted stock units 2,386 $ 1 2,385    
Issuance of common stock under ESPP (in shares)   155      
Issuance of common stock under ESPP 3,748   3,748    
Tax portion of vested restricted stock units (2,639)   (2,639)    
Stock-based compensation expense (employee) 18,459   18,459    
Stock-based compensation expense (non-employee) 11   11    
Stock-based compensation expense (ESPP) 1,397   1,397    
Net loss (32,716)     (32,716)  
Other comprehensive loss (38,983)       (38,983)
Balance at end of period (in shares) at Sep. 30, 2022   71,742      
Balance at end of period at Sep. 30, 2022 1,048,177 $ 72 1,492,044 (389,873) (54,066)
Balance at beginning of period (in shares) at Jun. 30, 2022   71,559      
Balance at beginning of period at Jun. 30, 2022 1,064,151 $ 72 1,483,279 (381,150) (38,050)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares)   110      
Issuance of common stock on exercise of stock options and vesting of restricted stock units 623   623    
Issuance of common stock under ESPP (in shares)   73      
Issuance of common stock under ESPP 1,633   1,633    
Tax portion of vested restricted stock units (773)   (773)    
Stock-based compensation expense (employee) 6,815   6,815    
Stock-based compensation expense (ESPP) 467   467    
Net loss (8,723)     (8,723)  
Other comprehensive loss (16,016)       (16,016)
Balance at end of period (in shares) at Sep. 30, 2022   71,742      
Balance at end of period at Sep. 30, 2022 $ 1,048,177 $ 72 $ 1,492,044 $ (389,873) $ (54,066)